Amgen biotech buying genetics firm

Biotech pioneer Amgen Inc., in a bid for a big edge in using people’s genetic information to find better ways to attack diseases, is buying human genetics research and analytics leader deCODE Genetics for $415 million.

See more here:

Amgen biotech buying genetics firm

Related Posts

Comments are closed.